SCHEMBL7092059

SCHEMBL7092059

O=C(CN1CCOCC1)Nc1ccc2c(c1)Cc1cn[nH]c1-2

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.59
PARP1 P09874 2/20 0.53
ALDH1A1 P00352 6/20 0.51
MEN1 O00255 1/20 0.51
POLB P06746 1/20 0.51
KMT2A Q03164 1/20 0.51
GAA P10253 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ATM Q13315 1/20 0.50
HPGD P15428 2/20 0.49
ALOX15 P16050 2/20 0.49
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4813967 0.81 MAPK1 (0.56) MAPK1PARP1ALDH1A1MEN1POLB
SCHEMBL4809769 0.80 RAB9A (0.50) MAPK1PARP1ALDH1A1POLBKMT2A
SCHEMBL7091559 0.78 CHEK1 (0.59) MAPK1PARP1ALDH1A1HPGDLMNA
SCHEMBL4818061 0.77 CHEK1 (0.68) MAPK1
SCHEMBL9630438 0.74 ALDH1A1 (0.64) MAPK1ALDH1A1MEN1POLBKMT2A
SCHEMBL9629545 0.71 SMN1; SMN2 (0.65) MAPK1PARP1ALDH1A1MEN1POLB
SCHEMBL11732314 0.70 TERT (0.78) MAPK1ALDH1A1MEN1POLBKMT2A
SCHEMBL13373415 0.70 LMNA (0.59) ALDH1A1MEN1POLBKMT2AGAA
SCHEMBL7696173 0.69 CHEK1 (0.66) PARP1HPGDALOX15HTTLMNA
SCHEMBL7095976 0.69 CHEK1 (0.55) PARP1ALDH1A1HPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed